Particulate drug delivery via hair follicles represents a promising concept, although requirements are high. This process must be realized at the desired depth and at the appropriate time, due to the fact that the particles themselves are not able to overcome the follicular skin barrier.
Introduction
Hair follicles represent an interesting target structure for drug delivery, since they are surrounded by a dense network of blood capillaries [1] [2] [3] which is important for a rapid uptake of topically applied drugs. Additionally, dendritic cells [2] and stem cells [3] , important for immunology and regenerative medicine, respectively, are closely associated with the hair follicles rendering them even more attractive for the development of selective drug delivery systems. Recently, it was demonstrated that particles in general [4] [5] [6] [7] [8] [9] and especially at a size between 300 and 600 nm penetrate very efficiently and deeper into the hair follicles than non-particulate substances [4, 10] . Likewise, the storage time was found to be increased by up to 10 days, in the case of the particulate substances, which is significantly longer than 4 days, as observed for the non-particulate substances [11, 12] .
As an explanation, Lademann et al. hypothesized that the surface structure of the hair and the hair follicle, as determined by the thickness of the keratin cells, which is in human hair of the order of 530 nm and in porcine hair of the order of 320 nm, might act as a pumping system which pushes the particulate substances mechanically into the hair follicles when the hairs are in motion [13] . In contrast, in vitro, the movement of the hair has to be simulated by a massage appliance [11] , under in vivo conditions, whereby a continuous movement of the hairs proceeds, pushing the particles efficiently and deeply into the hair follicles, if their size corresponds to the thickness of the keratin cells. Patzelt et al. [14] revealed that, depending on the size of the nanoparticles, different depths and thereby different target structures within the hair follicle can be reached.
However, the particles alone are not capable of reaching the target structures directly. Although, a transfollicular penetration of particles could be observed when the skin barrier was strongly disrupted [9] , several other studies demonstrated that particles of this dimension do not pass the intact barrier of the hair follicles [5, 15, 16] , Therefore, loading of the particles with a drug represents an efficient opportunity to transport the drug into the hair follicles provided that, after reaching the specific depth within the hair follicles, the drug is released from the particles to penetrate independently through the intact barrier of the hair follicles, as shown previously [17] .
A main advantage of this type of carrier system is the increased efficacy, as larger quantities of drugs can be administered to the contemplated target sites when transported by particles [18, 19] . Applying this carrier concept, it is essential to quickly release the drug from the particles onto the specified target structure, at the appropriate time [17] . The use of porous particles, continuously releasing the drug, seems to be less appropriate, since the release would already occur in the storage container before skin application. The application of defined amounts of drugs would thus be prevented. Recently, it could be demonstrated that the release of a model drug (fluorescent dye) from particles composed of bovine serum albumin (BSA) based on protein activation and spontaneous self-assembly technique at a size of 500 nm can be decomposed by an interaction of the protease [17] . In these experiments, the drug-containing particles were applied onto the skin before the protease contained in a liquid formulation was applied. The release procedure of the model drug from the particles was analyzed by the time dependent fluorescence properties of the dye, as described by Mak et al. [17] . It was found that the particles penetrated down to the sebaceous gland of the hair follicles, whilst the liquid protease penetrated only into the upper third part of the hair follicles. This behavior is typical for non-particulate substances. Consequently, drug release occurred only in the upper third of the hair follicles, whilst the deeper target structures were not able to interact with the drug.
Therefore, a novel concept to trigger the release of a drug from the particles inside the hair follicles is presented in the current study. It is based on the application of two different types of particles of the same size, supposed to penetrate efficiently into the hair follicles. One type of particle is the drug carrier, whereas the second particle type interacts with the drug-carrying particles and triggers the drug release. The drug release from the particles is investigated by changes in fluorescence properties of the model drug, as described by Mak et al. [17] . The concept of the penetration and release process is schematically depicted in Figure 1 . Schematic diagram of penetration and release concept
Materials and methods

Materials
Calcium chloride and sodium carbonate were purchased from Sigma-Aldrich The second type of particles consisted of CaCO 3 particles loaded with protease tagged with rhodamine (P prot ). With a mean diameter of 516 ± 37 nm, the size of P prot was similar to that of the drug loaded particles P drug . In brief, a solution containing protease (1 mg mL -1 ) and calcium chloride (0.5 M) was rapidly mixed with sodium carbonate (0.5 M) and continuously stirred for 30 seconds to produce P prot . The P prot was washed five times by centrifugation (2000 rpm, 2 minutes) and re-dispersed in 1X phosphate buffer saline (PBS) at pH 7.4. By means of this approach, the amount of protease molecules incorporated inside the CaCO 3 particles was determined by the physical interaction of the protease/CaCO 3 mixture during co-precipitation. Thus, protease molecules were slowly released from the CaCO 3 during storage until equilibrium had been reached between the encapsulated and the bulk phase protease, which was, however, not the aim of our study.
The particles applied in this study have a model function, in order to demonstrate the efficacy of the penetration of the particles and the effect of triggered drug release, close to the target structures.
These two types of particles are demonstrated to be biocompatible and of high cytocompatibility being also applicable to humans.
Tissue samples
As this work required a high number of biopsies, the investigations were performed in vitro on porcine ear skin due to ethical reasons. Porcine ear skin provides a structure similar to human skin [22, 23] and is well suited for the investigation of the penetration of particles into the hair follicles, as previously shown [4, 10, 14] . Excised human skin is not applicable for follicular penetration studies, since human skin contracts directly after excision which leads to a permanent occlusion of the hair follicles by the contracted elastic fibers [24] . On the contrary, porcine ear skin remains fixed to the cartilage during investigation and therefore the follicles remain open [25] . The pig ears had been freshly obtained from the butcher and the investigations were completed within six hours. Prior to treatment, the pig ears had been rinsed under cold water and dried with paper towels. Approval for the experiments had been obtained from the Veterinary Board, District of Berlin-TreptowKöpenick.
Application protocol
Three skin areas of 4 x 4 cm² were marked on each porcine ear skin sample. Both types of particles, P drug and P prot , were stored separately and were mixed directly prior to application at a relation 1:1. The mixture was then applied to the porcine skin on the first marked skin area (application protocol 1). On the neighboring skin area, pure P drug was exclusively applied (application protocol 2), the third skin area remained untreated as a control. In both cases the applied concentration was 2 mL/cm². The penetration of the particles into the skin was stimulated by a massage appliance for one minute, by means of the massage applicator (PC60, petra-electric, Burgau, Germany) in order to stimulate the movement of the hairs, similar to the in vivo situation.
Preparation of skin samples
Sixty minutes after application of the particles, circular biopsies of 3 mm diameter were removed from all skin areas treated with application protocol 1 or 2 and from the control area, respectively. The biopsies were shock frozen in liquid nitrogen and 10 µm cryo sections were prepared. The study was performed on 6 pig ears; for each tissue sample, at least 10 hair follicles were analyzed.
Sample analysis
The distribution of the particles in the cryo sections was determined by laser scanning microscopy in the transmission and fluorescent modes, utilizing the laser scanning microscope, LSM 2000 (Carl Zeiss, Jena, Germany) [17] . In the case of application protocol 1, when P drug and P prot were applied together, the fluorescent dyes, FITC and rhodamine, were excited at 488 nm by argon laser radiation, the fluorescence signal of FITC was detected at 520 nm and that of rhodamine at 590
nm. In the case of application protocol 2 (application of pure P drug ), only the fluorescence signal of FITC was detected.
In preliminary experiments, it was demonstrated that the fluorescence signal of the model drug FITC increased strongly, when P drug was dissolved after contact with P prot .
Electron scanning microscopy
The morphology of the particles was examined by scanning electron microscopy JSM-6700F (JEOL, Japan). Imaging samples were prepared by dropping the particle solution onto a flat silicon surface, air dried at room temperature and followed by gold deposition.
Statistic analysis
The penetration depths of the model drug FITC and the rhodamine-labelled protease particles were determined for at least 10 hair follicles per skin sample. 
Results
Typical images of the P drug and P prot obtained from electron scanning microscopy are shown in Fig. 2 . Both types of particles had a uniform spherical morphology with a similar average diameter of approximately 520 nm (532 ± 24 nm for P drug and 516 ± 37 nm for P prot ). The surface of the BSA particles (Fig. 2a ) appeared smooth and less porous, whereas the CaCO 3 particles showed seed-like agglomerates with a rough surface and large pores (Fig. 2b) . The difference in particle morphology explains why the model drug (FITC) was encapsulated and strongly linked to P drug , whereas protease slowly diffused out of P prot . The diffusion process started when P prot was applied onto the skin, as this resulted in a strong change in the concentration gradient of the protease from the particles to the environment (skin). It is essential that free protease can interact with P drug and cause decomposition of the particles, which releases the model drug inside the hair follicles. The intensity of the fluorescence signal, resulting from the model drug FITC detected in the histological sections, was approximately one order of magnitude higher than with P drug when P drug and P prot were applied as a mixture (Fig. 3a) , which was applied unaided (Fig 3b) . We note that no fluorescent signal could be detected for the control skin sites, and identical results were obtained for all hair follicles in all tissue samples. a b Figure 3 . Differences in the fluorescence intensity of the model drug FITC when P drug and P prot were applied in a mixture (a) or when P drug , was applied unaided without protease particles (b) Fig. 4 shows the average penetration depths of the P drug and P prot particles applied as a mixture (application protocol 1). In all investigated hair follicles, a strong fluorescence signal was observed at 520 nm demonstrating that the model drug was released from the P drug as a result of the interaction of both types of particles causing the release of the drug. The fluorescence signal of rhodamine (protease particles) at 590 nm was detected at similar penetration depths (p > 0.05). Additionally, in the case of application protocol 1, a strong fluorescence signal of fluoresceine was also detected in the sebaceous glands (Fig. 5a) , whereas, when only P drug was applied unaided, not even a weak fluorescence signal could be observed in the region of the sebaceous glands (Fig. 5b) . 
Discussion
Particle sizes between 300 nm and 600 nm penetrate more efficiently and deeper into the hair follicles than non-particulate substances [10] . However, particles in this size range are not able to overcome the intact skin barrier, neither the barrier of the stratum corneum nor the barrier of the hair follicles [5] . Efficient drug delivery through the skin barrier, however, can be obtained, if the particles are employed as carrier systems loaded with the drug of interest. In this case, the particle can deliver the drug close to the target structure of interest in the hair follicles where the drug is released and passes independently the skin barrier of the hair follicle. There is evidence that molecules, being transported into the hair follicles, are able to pass the barrier of the hair follicles and thus reach the living cells. This was shown, e.g., for the penetration of caffeine [26] and minoxidil [27] . In these experiments, the hair follicles were artificially closed, enabling a clear differentiation between follicular and intercellular penetration [28] . These studies revealed a faster penetration via the follicular pathway than the intercellular penetration pathway. Pharmacokinetic calculations revealed the absorption rate constant of caffeine for hair follicles to be nearly 10 times higher than that for the stratum corneum and the fraction of absorption from hair follicles was more than half of that of the stratum corneum [29] .
Particulate drug delivery via hair follicles, thus, represents a promising concept although the requirements are high, as the release of the active drug close to the target site of interest has to be realized at the desired depth and at the appropriate time. The penetration depths of the particles can be easily controlled by the particle size. Therefore, the drug release needs to be stimulated by a suitable trigger process.
In the present study, an advanced delivery system based on the interaction of drug loaded particles (P drug ) with the triggering reagent protease, also being applied via particle formulation (P prot ), was used to trigger the drug release inside the hair follicles. In contrast to the previous study reported by Mak et al. [17] , where the protease was applied in form of a solution together with the drug loaded particles, a mixed particle formulation composed of P drug and P prot was applied for delivery and triggered release of drugs within the hair follicles close to the corresponding target structure. As P drug and P prot were of similar size, the penetration depths of both types of particles into the hair follicles were almost identical. A slight but not significantly increased penetration depth for the model drug FITC can be explained by a further independent penetration of the model drug after release. After topical application, a strong change in the concentration gradient for protease occurs, which induces protease to diffuse from the particle carriers, after which the protease triggers the release of the model drug inside the hair follicles.
Application of protease in a non-particulate form, e.g., a liquid formulation, as reported by Mak et al. [17] , resulted in penetration of the protease only into the upper part of the hair follicles and, consequently, release of the model drug only occurred in this upper region. The present study enabled a deeper penetration also of the protease by being delivered via particles. It was demonstrated in the previous study that no significant decomposition of P drug occurred when the particles interacted with 0.1% protease solution for 5 minutes [17] . An interaction time of one hour is required for the complete release of the model drug from P drug . It is understandable that the release of the model drug occurs only after the penetration process of the particles is almost completed, since penetration of the particle mixture into the hair follicles occurs mainly during the massage procedure.
In the case of P drug being applied unaided onto skin, only a weak fluorescence signal from the model drug could be observed. A possible explanation for this effect could be the self-quenching between the fluorescence molecules, which might result from the higher concentration of the drug loaded in the particles. The results of the preliminary experiments demonstrated that the fluorescence intensity of the model drug was significantly higher when it had been released from the particles. This effect was also demonstrated in the present study, where a release of the model drug could be detected in the hair follicles even up to nearly 1 mm in depth.
Additionally, it was observed that, as a result of the interaction of both types of particles (P drug and P prot ), the released model drug could be clearly detected in the sebaceous glands showing a strong fluorescence signal. This effect was not observed when the drug-loaded particles had been applied unaided. Consequently, it can be assumed that not the particles penetrate into the sebaceous glands, rather than exclusively the released model drug, which could be of interest for the development of new therapeutic strategies for the treatment of sebaceous gland associated diseases, such as acne vulgaris.
Under in vivo conditions, the drug being delivered close to the target structure must pass through the barrier of the hair follicles independently to reach the living cells and the blood circulation. The surfaces of the follicular openings are only initially keratinized while in the lower infundibulum, the corneocytes are smaller and crumbly and more penetrable, suggesting that the barrier is incomplete in this region [30, 31] .
The efficiency of penetration of the released drug through the barrier of the hair follicles depends on the physicochemical properties and especially the size of the drug molecules [30] . Therefore, the penetration process of the released drug through the follicular barrier into the living cells must be separately evaluated for each single drug.
As far as safety aspects are concerned, the substances used in the present study can be applied in vivo onto human skin. In the present study, the substances had only a model character in order to demonstrate the perspective of triggering a drug release from the particles at the target structure inside the hair follicles. Therefore, no direct clinical application was intended in this work.
Conclusions
Drug delivery by means of particles into hair follicles is a promising process, since the hair follicles offer several target sites of therapeutical interest. The cavities of the hair follicle permit long-term storage of drugs to achieve sustained release. The triggered release of drugs from the particles inside the hair follicles is essential in the delivery process. The results of the present study demonstrate an advanced triggering system based on a mixed particle formulation for the efficient release of the model drugs from the particle carrier inside hair follicles. The model drug was found to be distributed within the hair follicles, as well as in the sebaceous glands. Although the release system has still to be evaluated for further model drugs, drug molecules and particle types, it provides an important and promising new approach for the treatment of different types of skin diseases, for instance, acne vulgaris, 
